These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15722065

  • 21. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.
    Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
    [Abstract] [Full Text] [Related]

  • 22. Bone mineral density and history of oral contraceptive use.
    Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE.
    J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
    [Abstract] [Full Text] [Related]

  • 23. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L, Denny L, Wright TC, Kuhn L.
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [Abstract] [Full Text] [Related]

  • 24. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
    Walsh JS, Eastell R, Peel NF.
    Fertil Steril; 2010 Feb; 93(3):697-701. PubMed ID: 19013564
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
    Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y.
    Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
    [Abstract] [Full Text] [Related]

  • 27. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS, Tang G, Yip P, Li B, Fan S.
    Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 38. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
    Beksinska ME, Kleinschmidt I, Smit JA, Farley TM, Rees HV.
    Contraception; 2009 Aug; 80(2):128-32. PubMed ID: 19631787
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.